Vitamin D and psychosis: Mini meta-analysis

Schizophrenia Research

Volumn 150, Issue 1, 2013, Pages 235-239

  Belvederi Murri, Martino ^a,b   Respino, Matteo ^c   Masotti, Mattia ^c   Innamorati, Marco ^a   Mondelli, Valeria ^b   Pariante, Carmine ^b   Amore, Mario ^c  

^a UNIVERSITY OF PARMA   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Psychosis; Schizophrenia; Vitamin D

Indexed keywords

VITAMIN D;

DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

PSYCHOSIS; SCHIZOPHRENIA; VITAMIN D;

HUMANS; PSYCHOTIC DISORDERS; PUBMED; VITAMIN D DEFICIENCY;

EID: 84884148755     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.07.017     Document Type: Review

References (28)

1. Berg A.O., Melle I., Torjesen P.A., Lien L., Hauff E., Andreassen O.A. A cross-sectional study of vitamin D deficiency among immigrants and Norwegians with psychosis compared to the general population. J. Clin. Psychiatry 2010, 71(12):1598-1604.
2. Bonnot O., Inaoui R., Raffin-Viard M., Bodeau N., Coussieu C., Cohen D. Children and adolescents with severe mental illness need vitamin D supplementation regardless of disease or treatment. J. Child Adolesc. Psychopharmacol. 2011, 21(2):157-161.
3. Dealberto M.J. Clinical symptoms of psychotic episodes and 25-hydroxy vitamin D serum levels in black first-generation immigrants. Acta Psychiatr. Scand 2013, (Epub ahead of print). 10.1111/acps.12086.
4. Doknic M., Maric N.P., Britvic D., Pekic S., Damjanovic A., Miljic D., Stojanovic M., Radojicic Z., Jasovic G.M., Popovic V. Bone remodeling, bone mass and weight gain in patients with stabilized schizophrenia in real-life conditions treated with long-acting injectable risperidone. Neuroendocrinology 2011, 94(3):246-254.
5. Eyles D.W., Burne T.H., McGrath J.J. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front. Neuroendocrinol. 2013, 34(1):47-64.
6. Gracious B.L., Finucane T.L., Friedman-Campbell M., Messing S., Parkhurst M.N. Vitamin D deficiency and psychotic features in mentally ill adolescents: a cross-sectional study. BMC Psychiatry 2012, 12:38.
7. Hedelin M., Lof M., Olsson M., Lewander T., Nilsson B., Hultman C.M., Weiderpass E. Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population. BMC Psychiatry 2010, 10:38.
8. Higgins J.P.T., Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 2011, (updated March 2011), (accessed on April 1st, 2013). http://www.cochrane-handbook.org.
9. Howard R., Reeves S. Psychosis and schizophrenia-like disorders in the elderly. J. Nutr. Health Aging 2003, 7(6):410-411.
10. Humble M.B., Gustafsson S., Bejerot S. Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis. J Steroid Biochem. Mol. Biol 2010, 121(1-2):467-470.
11. Itzhaky D., Amital D., Gorden K., Bogomolni A., Arnson Y., Amital H. Low serum vitamin D concentrations in patients with schizophrenia. Isr. Med. Assoc. J. 2012, 14(2):88-92.
12. Jamilian H., Bagherzadeh K., Nazeri Z., Hassanijirdehi M. Vitamin D, parathyroid hormone, serum calcium and phosphorus in patients with schizophrenia and major depression. Int. J. Psychiatry Clin. Pract. 2013, 17(1):30-34.
13. Khazai N., Judd S.E., Tangpricha V. Calcium and vitamin D: skeletal and extraskeletal health. Curr. Rheumatol. Rep. 2008, 10(2):110-117.
14. Kishimoto T., De H.M., Carlson H.E., Manu P., Correll C.U. Osteoporosis and fracture risk in people with schizophrenia. Curr. Opin. Psychiatry 2012, 25(5):415-429.
15. Lapid M.I., Drake M.T., Geske J.R., Mundis C.B., Hegard T.L., Kung S., Frye M.A. Hypovitaminosis d in psychogeriatric inpatients. J. Nutr. Health Aging 2013, 17(3):231-234.
16. Masi G., Mucci M., Pari C. Children with schizophrenia: clinical picture and pharmacological treatment. CNS Drugs 2006, 20(10):841-866.
17. McGrath J.J., Kimlin M.G., Saha S., Eyles D.W., Parisi A.V. Vitamin D insufficiency in south-east Queensland. Med. J. Aust. 2001, 174(3):150-151.
18. Menkes D.B., Lancaster K., Grant M., Marsh R.W., Dean P., du Toit S.A. Vitamin D status of psychiatric inpatients in New Zealand's Waikato region. BMC Psychiatry 2012, 12:68.
19. Milaneschi Y., Hoogendijk W., Lips P., Heijboer A.C., Schoevers R., van Hemert A.M., Beekman A.T., Smit J.H., Penninx B.W. The association between low vitamin D and depressive disorders. Mol. Psychiatry 2013, (Epub ahead of print). 10.1038/mp.2013.36.
20. Muir S.W., Montero-Odasso M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J. Am. Geriatr. Soc. 2011, 59(12):2291-2300.
21. Partti K., Heliovaara M., Impivaara O., Perala J., Saarni S.I., Lonnqvist J., Suvisaari J.M. Skeletal status in psychotic disorders: a population-based study. Psychosom. Med. 2010, 72(9):933-940.
22. Rey-Sanchez P., Lavado-Garcia J.M., Canal-Macias M.L., Gomez-Zubeldia M.A., Roncero-Martin R., Pedrera-Zamorano J.D. Ultrasound bone mass in schizophrenic patients on antipsychotic therapy. Hum. Psychopharmacol. 2009, 24(1):49-54.
23. Schneider B., Weber B., Frensch A., Stein J., Fritz J. Vitamin D in schizophrenia, major depression and alcoholism. J. Neural Transm. 2000, 107(7):839-842.
24. Suzuki M., Yoshioka M., Hashimoto M., Murakami M., Noya M., Takahashi D., Urashima M. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am. J. Clin. Nutr. 2013, 97(5):1004-1013.
25. Tolppanen A.M., Sayers A., Fraser W.D., Lewis G., Zammit S., McGrath J., Lawlor D.A. Serum 25-hydroxyvitamin D3 and D2 and non-clinical psychotic experiences in childhood. PLoS One 2012, 7(7):e41575. 10.1371/journal.pone.0041575.
26. Vieth R. Why the minimum desirable serum 25-hydroxyvitamin D level should be 75nmol/L (30ng/ml). Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25(4):681-691.
27. White T., Cullen K., Rohrer L.M., Karatekin C., Luciana M., Schmidt M., Hongwanishkul D., Kumra S., Charles S.S., Lim K.O. Limbic structures and networks in children and adolescents with schizophrenia. Schizophr. Bull. 2008, 34(1):18-29.
28. Zanetidou S., Belvederi Murri M., Buffa A., Malavolta N., Anzivino F., Bertakis K. Vitamin D supplements in geriatric major depression. Int. J. Geriatr. Psychiatry 2011, 26(11):1209-1210.